Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06300320 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06300320 · ClinicalTrials.gov record · last posted 2026-08-26

A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

StatusRecruiting
PhasePhase 2
Started2024-05-07
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is an open, multi-center clinical study designed to evaluate the efficacy and safety of TQ05105 Tablets in patients with chronic graft-versus-host disease

Protocol amendment history 3 changes detected by DataLookout

2026-08-27
Enrollment increased: 52 → 65 participants
2026-08-27
Primary completion pushed: 2025-10 → 2027-11
2026-08-27
Completion pushed: 2026-04 → 2029-05
Trial Details
NCT Number NCT06300320
Lead Sponsor Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions Chronic Graft Versus Host Disease
Enrollment 65 participants
Start Date 2024-05-07
Primary Completion 2027-11 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-26